Influence of local inflammation of the peritoneal membrane on diuresis and residual renal function in patients treated with peritoneal dialysis

被引:8
作者
Jelicic, Ivo [1 ]
Ljutic, Dragan [1 ]
Sain, Milenka [1 ]
Kovacic, Vedran [1 ]
Radic, Josipa [1 ]
机构
[1] Univ Hosp Split, Renal Unit, Split, Croatia
关键词
Peritoneal dialysis; Interleukin-6; Residual renal function; Diuresis; RELATIVE CONTRIBUTION; INTERLEUKIN-6; MORTALITY; ADEQUACY; HYPERTROPHY; CLEARANCE; SURVIVAL; RECEPTOR;
D O I
10.1007/s10047-011-0603-7
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The aim of this study was to investigate the connection between local inflammation of the peritoneal membrane and diuresis, as well as the residual renal function (RRF) in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Twenty patients treated with CAPD participated in this cross-sectional study. To determine the influence of local inflammation of the peritoneal membrane, effluent interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R) levels were measured. The level of IL-6, in the group as a whole, was significantly higher in effluent (7.87 pg/mL) than in serum (1.29 pg/mL). There was a significant correlation between effluent and serum IL-6 (r = 0.608; P = 0.002). There was also a significant relationship between effluent and serum IL-6 and duration of CAPD treatment, respectively (r = 0.577; P = 0.004; r = 0.528; P = 0.008). Further, there was a significant negative correlation between effluent IL-6 and daily diuresis (r = 0.533; P = 0.008), but there was no significant correlation between effluent IL-6 and RRF (r = -0.339, P = 0.072). On the other hand, the concentrations of effluent IL-6 were significantly higher in patients with RRF <2 mL/min than in those with RRF >= 2 mL/min (P = 0.039). In conclusion, local inflammation has a significant impact on the amount of diuresis and probably on RRF in patients on CAPD.
引用
收藏
页码:65 / 70
页数:6
相关论文
共 30 条
[1]  
Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158
[2]  
Biffl WL, 1999, ARCH SURG-CHICAGO, V134, P1331
[3]   Poor outcomes for fast transporters on PD: The rise and fall of a clinical concern [J].
Chung, Sung Hee ;
Heimbuerger, Olof ;
Lindholm, Bengt .
SEMINARS IN DIALYSIS, 2008, 21 (01) :7-10
[4]   What really happens to people on long-term peritoneal dialysis? [J].
Davies, SJ ;
Phillips, L ;
Griffiths, AM ;
Russell, LH ;
Naish, PF ;
Russell, GI .
KIDNEY INTERNATIONAL, 1998, 54 (06) :2207-2217
[5]  
European Best Practice Guidelines Expert Group on Hemodialysis European Renal Association, 2002, Nephrol Dial Transplant, V17 Suppl 7, P7
[6]   Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis [J].
Fusshoeller, Andreas .
PEDIATRIC NEPHROLOGY, 2008, 23 (01) :19-25
[7]   Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients [J].
Han, Seung Hyeok ;
Lee, Sang Choel ;
Ahn, Song Vogue ;
Lee, Jung Eun ;
Kim, Dong Ki ;
Lee, Tae Hee ;
Moon, Sung Jin ;
Kim, Beom Seok ;
Kang, Shin-Wook ;
Choi, Kyu Hun ;
Lee, Ho Yung ;
Han, Dae-Suk .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (09) :2653-2658
[8]   Serum albumin, C-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD [J].
Honda, H ;
Qureshi, AR ;
Heimbürger, O ;
Barany, P ;
Wang, K ;
Pecoits-Filho, R ;
Stenvinkel, P ;
Lindholm, B .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (01) :139-148
[9]   IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation [J].
Hurst, SM ;
Wilkinson, TS ;
McLoughlin, RM ;
Jones, S ;
Horiuchi, S ;
Yamamoto, N ;
Rose-John, S ;
Fuller, GM ;
Topley, N ;
Jones, SA .
IMMUNITY, 2001, 14 (06) :705-714
[10]   The soluble interleukin 6 receptor: mechanisms of production and implications in disease [J].
Jones, SA ;
Horiuchi, S ;
Topley, N ;
Yamamoto, N ;
Fuller, GM .
FASEB JOURNAL, 2001, 15 (01) :43-58